Monday - Friday:
9:00am - 5:00pm (EST)
Bluebird Bio announced that the first subject with severe sickle cell disease has undergone infusion with LentiGlobin BB305 drug product in an autologous hematopoietic stem cell transplantation.
Tune in to our web cast streaming live from the 42nd Annual National Convention. Become part of the conversation & Share your thoughts with the world. Follow @SCDAAorg on Twitter! Then Tweet your Thoughts and include the Official 2014 Convention Hash Tag #SCDC14
Sickle Cell Disease Association of America, Inc.
231 E. Baltimore Street,
Baltimore, MD 21202
Toll Free 800.421.8453